story of the week
Brentuximab Vedotin With Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
N. Engl. J. Med 2022 Nov 03;387(18)1649-1660, SM Castellino, Q Pei, SK Parsons, D Hodgson, K McCarten, T Horton, S Cho, Y Wu, A Punnett, H Dave, TO Henderson, BS Hoppe, AM Charpentier, FG Keller, KM KellyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.